Codexis, Inc. Q4 2025 Earnings Call Summary

Codexis, Inc. reported a stronger than expected Q4 2025 with a revenue increase of 15% year-over-year, driven by robust demand for its enzyme production technology. The company highlighted significant growth in its biomanufacturing segment, augmenting its full-year guidance for 2026. Investors responded positively to the news, leading to an after-hours stock price increase. Analysts are optimistic about the company's strategic partnerships, which are expected to further enhance revenue streams. Overall, the earnings call set a bullish tone for Codexis' future potential.